eSense-Cancer: Adapting an Online Intervention for Sexual Health Concerns to Gynecologic Cancer
NCT06619769
Summary
Sexual health is a vital component of gynecologic cancer treatment and survivorship. Unfortunately, most gynecologic cancer survivors lack sufficient information about the impact of cancer on sexual health and treatment opportunities. This research aims to assess how well an adapted online health intervention meets the sexual health needs of gynecologic cancer survivors and to test the efficacy of the new platform. If successful, eSense-Cancer may increase access to treatment for gynecologic cancer survivors, including those living in remote areas or facing other accessibility barriers. It may also fill healthcare gaps for survivors of varying ethnicity, sexual orientation, socioeconomic status, and gender.
Eligibility
Inclusion Criteria: * self-report a current or history of gynecologic cancer of any subtype * self-report symptoms of sexual difficulties and score of greater than 11 on the Female Sexual Distress Scale-Revised * are fluent in English (eSense content is delivered in English) * have reliable internet access and basic competency in using online platforms (individuals will self-report) * are available for 8 - 16 weeks and able to complete eSense modules and associated questionnaires * any gender Exclusion Criteria: * have visual impairments or disabilities interfering with reading and ability to interact with online materials * have poorly managed anxiety or mood disorder (assessed using the degree of life interference evaluation at screening) * individuals who are in active treatment for their cancer (including radiation, chemotherapy and any planned surgeries).
Conditions2
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06619769